These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3389252)

  • 41. In vivo modification of the C-terminal lysine of human lens alphaB-crystallin.
    Lin P; Smith DL; Smith JB
    Exp Eye Res; 1997 Nov; 65(5):673-80. PubMed ID: 9367647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of the corneal endothelium after artisan lens implantation for unilateral traumatic and unilateral congenital cataract in children: two case series.
    Odenthal MT; Sminia ML; Prick LJ; Gortzak-Moorstein N; Völker-Dieben HJ
    Cornea; 2006 Dec; 25(10):1173-7. PubMed ID: 17172893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management and outcomes of descemet stripping automated endothelial keratoplasty with intraocular lens exchange, aphakia, and anterior chamber intraocular lens.
    Hsu M; Jorgensen AJ; Moshirfar M; Mifflin MD
    Cornea; 2013 May; 32(5):e64-8. PubMed ID: 23086374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Calcium activated proteolysis and protein modification in the U18666A cataract.
    Chandrasekher G; Cenedella RJ
    Exp Eye Res; 1993 Dec; 57(6):737-45. PubMed ID: 8150025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiated treatment of secondary cataract following extracapsular cataract operation.
    Adank AM; Hennekes R
    Bull Soc Belge Ophtalmol; 1994; 254():37-40. PubMed ID: 7493121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomic analysis of water insoluble proteins from normal and cataractous human lenses.
    Harrington V; Srivastava OP; Kirk M
    Mol Vis; 2007 Sep; 13():1680-94. PubMed ID: 17893670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Localization of biologically uncommon D-beta-aspartate-containing alphaA-crystallin in human eye lens.
    Fujii N; Shimo-Oka T; Ogiso M; Momose Y; Kodama T; Kodama M; Akaboshi M
    Mol Vis; 2000 Feb; 6():1-5. PubMed ID: 10706893
    [TBL] [Abstract][Full Text] [Related]  

  • 48. sHSP in the eye lens: crystallin mutations, cataract and proteostasis.
    Clark AR; Lubsen NH; Slingsby C
    Int J Biochem Cell Biol; 2012 Oct; 44(10):1687-97. PubMed ID: 22405853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Contact lens correction in aphakia in children].
    Vasinca D; Vasinca D; Mihalachi C
    Oftalmologia; 1995; 39(1):69-75. PubMed ID: 7766584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optical correction of aphakia following unilateral infantile cataract removal.
    Li Q; Fu T; Li ZE; Bi HS; Wang XR; Dong M; Xin T
    Acta Ophthalmol; 2014 Dec; 92(8):e657-62. PubMed ID: 24930475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aphakia correction with rigid contact lenses in congenital cataract].
    Loudot C; Jourdan F; Benso C; Denis D
    J Fr Ophtalmol; 2012 Oct; 35(8):599-605. PubMed ID: 22634024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ominous retinal changes in aphakia].
    Kutschera E
    Klin Monbl Augenheilkd; 1980 Jan; 176(1):67-9. PubMed ID: 7412168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Degradation of gamma D- and gamma s-crystallins in human lenses.
    Srivastava OP; Srivastava K
    Biochem Biophys Res Commun; 1998 Dec; 253(2):288-94. PubMed ID: 9878530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lacrimal immunoglobulins in aphakic patients wearing permanent corneal lenses].
    Secchi AG; Mannucci LL
    Bull Mem Soc Fr Ophtalmol; 1983; 95():186-9. PubMed ID: 6677309
    [No Abstract]   [Full Text] [Related]  

  • 55. Thioredoxin, thioredoxin reductase, and alpha-crystallin revive inactivated glyceraldehyde 3-phosphate dehydrogenase in human aged and cataract lens extracts.
    Yan H; Lou MF; Fernando MR; Harding JJ
    Mol Vis; 2006 Oct; 12():1153-9. PubMed ID: 17093401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A covalent change in alpha crystallin during opacification of the Emory mouse lens.
    Takemoto L; Horwitz J; Kuck J; Kuck K
    Lens Eye Toxic Res; 1989; 6(3):431-41. PubMed ID: 2486937
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment potentials in senile cataract].
    Naumann GO
    Dtsch Med Wochenschr; 1984 Jan; 109(2):64-7. PubMed ID: 6692766
    [No Abstract]   [Full Text] [Related]  

  • 58. Prospects for contact lens wear in aphakia.
    Graham CM; Dart JK; Wilson-Holt NW; Buckley RJ
    Eye (Lond); 1988; 2 ( Pt 1)():48-55. PubMed ID: 3165873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resistance of human betaB2-crystallin to in vivo modification.
    Zhang Z; David LL; Smith DL; Smith JB
    Exp Eye Res; 2001 Aug; 73(2):203-11. PubMed ID: 11446770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ontogeny and localization of the crystallins during lens development in normal and Hy-1 (hyperplastic lens epithelium) chick embryos.
    McDevitt DS; Clayton RM
    J Embryol Exp Morphol; 1979 Apr; 50():31-45. PubMed ID: 379264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.